NEWSpublisher 2007 :: AngloChinese Investments
date from:
date to:
search for string:
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY NEWS » Industry news  «  1  2  3  4  5  » 
found files: 758
»25/05/2007 [Industry news]
The first contract research service alliance (CROSA) in China

The first contract research service alliance (CROSA) in China has been formed between three leading local firms to provide a more exhaustive range of drug development services to pharma companies....   more»

»22/05/2007 [Industry news]
PharmEng International Inc. ("PharmEng today that it has established a joint venture company

PharmEng International Inc. announced today that it has established a joint venture company in partnership with Beijing BRD Lixin PharmaTech Co. Ltd.("Lixin") of China to provide consulting and pharmaceutical development services in China. PharmEng will own 51% of the joint venture company, headquartered in Beijing, China and will operate under the name Beijing PharmEng BRD Lixin PharmaTech Consultation Co. Ltd....   more»

»22/05/2007 [Industry news]
Foreign investors are snapping up shares of companies in China's growing but under-regulated pharmaceutical industry, even as a string of deadly scandals has tainted the sector.

Comment:: Its not just foreign investors! China's Gvmt is threatening to bring in measures to contain the trading in shares by the ordinary chinese people, causing ridiculous inflated values to some of the listed companies. It's creating a scenario similar to the dotcom era experienced here in the west....   more»

»21/05/2007 [Industry news]
Protagen and ZAP partner with Kangdi Antibody Biotech and Bejing Proteome Research Centre to develop

Protagen announced its partnership with the Centre for Applied Proteomics (ZAP), Dortmund, Schunde Kangdi Antibody Biotech, Foshan, China and the Beijing Proteome Research Centre (Beijing PRC) today at the interna?tional symposium on High Performance Proteomics in Dortmund....   more»

»03/06/2007 [Industry news]
Now China targets traditional medicine factory

China has raided a filthy underground fake medicine factory, Chinese media reported on Thursday, as the country faces a series of food and medicine safety scandals at home and abroad....   more»

Simcere Pharmaceutical Group »03/06/2007 [Industry news]
Simcere Pharmaceutical Group is looking to build its future on research

Flush with cash from its US IPO, Simcere Pharmaceutical Group is looking to build its future on research. Late last month, Simcere weighed in with the largest IPO on the New York Stock Exchange for an Asian pharmaceutical company, raising 261 mln usd. Now it plans to put some of that money to work. 'We need to consider both the long-term and the short-term,' said Jinsheng Ren, chairman and CEO. 'Pharmaceutical technology can really set companies apart in China and that is why we say R & D is our focus.' "THIS HIGHLY RESPECTED COMPANY COULD BE A GOOD PARTNER FOR HLS"...   more»

Pfizer »24/05/2007 [Industry news]
Pfizer Says Research and Development Head John LaMattina Will Retire This Year

Pfizer said today that the President of Pfizer Global Research and Development, Dr. John LaMattina, who made many important contributions to the Company‚Äôs research division throughout his 30-year career, will retire from Pfizer by the end of this year. The company will begin a search both inside and outside the company for his successor, and Dr. LaMattina has agreed to remain during this period to ensure a smooth transition....   more»

Merck & Co »20/05/2007 [Industry news]
Merck Announces Resignation of Peter Loescher, President, Global Human Health

WHITEHOUSE STATION, N.J., May 20, 2007 - Merck & Co., Inc. today announced the resignation of Peter Loescher, president, Global Human Health. Effective July 1, 2007, Mr. Loescher, 49, will take on the position of president and chief executive officer at Siemens AG. "We thank Peter for his contributions to Merck and wish him and his family well in this new endeavor," said Richard T. Clark, chairman, president and chief executive officer. "Merck remains fully committed to the strategic initiatives and operating goals established for the Global Human Health (GHH) organization. We continue to be pleased with the strong business performance across all the GHH franchises and regions, and we are confident that it will continue." Mr. Loescher will remain for a period of time to help with the leadership transition. Merck expects to name a new leader for the GHH organization so...   more»

»29/05/2007 [Industry news]
China sentences former drug official to death

China has today sentenced to death the former director of its State Food and Drug Administration (SFDA), on charges of corruption, according to reports in the Chinese media...   more»

»24/05/2007 [Industry news]
Gates Foundation Opens Beijing Office To Increase HIV Prevention Efforts In China

The Bill & Melinda Gates Foundation has opened an office in Beijing to increase HIV prevention efforts in China and control the spread of the virus in the country....   more»

»25/05/2007 [Industry news]
Siemens joins hospital venture

German conglomerate Siemens and hospital operator Asklepios Kliniken yesterday signed an agreement with Tongji University to jointly build a 1-billion-yuan Sino-German Friendship Hospital in Shanghai....   more»

»11/06/2007 [Industry news]
Chinese Drug/Food Safety Plan Announced

In a bid to better control the current poor levels of regulation within the drug and food sectors, the Chinese Government is set to implement a long-term plan, designed to combat bad foods and dangerous medicines. The offensive, with a planned duration of five years, was announced amid a recent flurry of national and international health scandals that have exposed China's lackadaisical approach to regulation at present. Products that have been identified as sub-standard include locally produced medicines, toothpaste, pet foods and farm produce. China has come under much fire, particularly from the US, which has highlighted China's infiltration of the worldwide marketplace with fake products; these, it alleges, potentially endangering consumer health. Indeed, officials in Panama are adamant that around 100 deaths there have been caused by drug ingredients imported from China. The US recently prohibited certain Chinese-produced animal feed, on account of it containing an illegal additive in vegetable protein, which can on occasion be addictive. The most recent country to lambast Chinese product is Singapore, which only last week banned a selection of toothpastes after small amounts of a potentially dangerous additive were found to be present. Li Changjiang, the Minister of China's General Administration of Quality Supervision, Inspection and Quarantine, has publicly detailed the diplomatic headache caused by the bad international press these events have caused. His comments, published yesterday on the body's website, included the statement that: "Food safety work isn't just a law enforcement and vigilance involves the national image, it involves bilateral and even multilateral political relations." In light of these events, a statement has now been published on the Chinese Government's website, urging that: "Ensuring food and pharmaceutical safety for the public must be the starting point and destination of all work." Among the key features of the five-year overhaul plan detailed in the statement are dedicated inspections of the majority of food production firms, tough controls preventing over-use of pesticides and additives within the farming community and manufacturing industry, and the monitoring of adverse reactions to drugs across China. Regarding these elements, the online mission-statement advises that: "Monitoring and administering food and pharmaceutical safety must be at the very heart of grassroots and base work." The five-year plan stresses that, in years to come, "illegal activities behind production and sale of fake and shoddy foods and pharmaceuticals will be effectively contained...   more»

»18/06/2007 [Industry news]
Alpharma Inc. (ALO) Acquires Additional Animal Health Assets in China

BRIDGEWATER, NJ (MARKET WIRE) Jun 18, 2007 Alpharma Inc. (NYSE:ALO - News), a leading global specialty pharmaceutical company, announced it has acquired certain assets of Yantai JinHai Pharmaceutical Co. Ltd. located in Yantai City, Shandong Province, China....   more»

»14/06/2007 [Industry news]
China Shenghuo Pharmaceutical Holdings, Inc. Announces Listing on AMEX and Closing of Public Offering

KUNMING, China, June 14 /Xinhua-PRNewswire-FirstCall/ -√ā¬®C China Shenghuo Pharmaceutical Holdings, Inc. announced the listing of its common stock on the American Stock Exchange on Thursday, June 14, 2007, and the closing of a public offering of its common stock at an offering price of $3.50 per share on Thursday, June 14, 2007....   more»

»20/06/2007 [Industry news]
Inefficient IPR protection curbs R & D outsourcing in China

Shanghai. June 20. INTERFAX-CHINA - Inefficient intellectual property rights protection is a factor preventing multinational companies from outsourcing pharmaceutical R & D and production to China, business insiders said at the 2007 CPhI International Forum in Shanghai yesterday....   more»

»25/06/2007 [Industry news]
Third Chinese drug official charged in corruption scandal

China\'s resolve to clean up corruption in its pharma industry has intensified as the former assistant to the already-condemned-to-death former drug chief has now been charged....   more»

»15/06/2007 [Industry news]
SFDA Newletter of April

To conscientiously strengthen the publicity and be actively supervised by public opinions The center for Drug Evaluation will enlarge the announcement range of reviewers New trends in the evaluating policies for TCM registration: Special evaluation on the innovative drugs and the higher access standards for TCM varieties under protection Recruitment for members of the ‚ÄúTechnical Subcommittee of Dental Devices and Instruments for the National Technical Standardization Committee for Dental Materials and Instruments‚ÄĚ The Provisions of Drug Advertising Review are revised, and the illegal advertisements will be seriously punished The new version of Drug Advertising Review and Dissemination Standards was published SFDA issued a notice on matters relating to drug re-registration...   more»

»25/06/2007 [Industry news]
SFDA Newletter of May

The General office of the state Council issued the Eleventh Five-year Plan of the National Food and Drug Safety The Technical Guidelines for the Clinical Study of the In Vitro Diagnostic Reagents and the Guidelines for the Inert Sheet Compilation of In Vitro Diagnostic Reagents were Issued The ‚ÄúStudy of Techniques of Fast Inspection on Drugs and the Application of its Carries-Drug Inspection Van‚ÄĚ Program passed the form examination of the National Awards Office The Administrative Measures for In Vitro Diagnostic Reagents Registration (Interim) have been issued SFDA issued new requirements for GLP certification Provision for Drug Registration (Draft for Comment) Workshop was held The Second International Pharmaceutical R&D Forum was held in Beijing...   more»

»11/07/2007 [Industry news]
Alpharma To Expand Vancomycin Capacity

Alpharma Pharmaceutical Co. has completed its agreement with Zhejiang Hisun Pharmaceutical Co. (Hisun), doubling its capacity to manufacture one of Hisun\'s major APIs, vancomycin, subject to FDA and European regulatory approvals. Vancomycin is for severe gram-positive hospital infections. Alpharma currently manufactures vancomycin at its sites in Copenhagen, Denmark and Budapest, Hungary....   more»

»10/07/2007 [Industry news]
China carries out execution on corrupt drug official

10/07/2007 - China has wasted no time in executing the first of its convicted corrupt former drug officials after his desperate appeal for life failed....   more»

AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.